Pulmonary arterial hypertension: current therapeutic strategies

被引：0
|
作者：
Aniket Puri
Michael D McGoon
Sudhir S Kushwaha
机构：
[1] A Puri is a Senior Research Associate in Cardiology at King George's Medical University,
[2] Lucknow,undefined
[3] India.,undefined
[4] MD McGoon is Professor of Medicine and Director of the Pulmonary Hypertension Clinic at Mayo Clinic.,undefined
[5] SS Kushwaha is an Associate Professor of Medicine and Consultant in Cardiology at Mayo Clinic,undefined
[6] Rochester,undefined
[7] MN,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pulmonary arterial hypertension (PAH) was once a lethal condition. As the number of therapeutic options available has risen, however, the treatment of PAH has evolved considerably. In this Review, Aniket Puri, Michael McGoon and Sudhir Kushwaha consider the current knowledge of the pathogenesis of PAH in relation to presently available and novel emerging therapies, including combination therapy, that hold promise for treatment as well as disease modification.
引用
收藏
页码：319 / 329
页数：10
相关论文
共 50 条
  • [21] Current treatment for pulmonary arterial hypertension
    Ghofrani, H. -A.
    Voswinckel, R.
    Reichenberger, F.
    Gall, H.
    Seeger, W.
    Grimminger, F.
    PNEUMOLOGE, 2010, 7 (03): : 192 - 198
  • [22] Current Therapies for Pulmonary Arterial Hypertension
    Takaoka, Shanon
    Faul, John L.
    Doyle, Ramona
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 11 (02) : 137 - 148
  • [23] Current Treatment of the Pulmonary Arterial Hypertension
    Gallego-Page, Juan C.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2007, 3 (02) : 129 - 134
  • [24] New insights into the molecular pathogenesis of pulmonary arterial hypertension: Relevance to novel therapeutic strategies
    Stewart, Duncan J.
    Yelle, Dominique
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 29B - 32B
  • [25] Novel therapeutic strategies in the management of arterial hypertension
    Tousoulis, Dimitris
    Androulakis, Emmanuel
    Papageorgiou, Nikolaos
    Stefanadis, Christodoulos
    PHARMACOLOGY & THERAPEUTICS, 2012, 135 (02) : 168 - 175
  • [26] Novel therapeutic perspectives in pulmonary arterial hypertension
    Humbert, M
    Sitbon, O
    Simonneau, G
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) : 193 - 194
  • [27] Novel Therapeutic Approaches of Pulmonary Arterial Hypertension
    Tyagi, Sanjay
    Batra, Vishal
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2019, 28 (02) : 112 - 117
  • [28] THERAPEUTIC EFFECTS OF ALOPERINE ON THE PULMONARY ARTERIAL HYPERTENSION
    Li, Shuang
    Zhou, Fubo
    Dong, Jianjiang
    Dong, Qi
    Luan, Hairong
    Li, Li
    Hao, Yankun
    FARMACIA, 2019, 67 (04) : 691 - 701
  • [29] Therapeutic implications of microRNAs in pulmonary arterial hypertension
    Lee, Aram
    McLean, Danielle
    Choi, Jihea
    Kang, Hyesoo
    Chang, Woochul
    Kim, Jongmin
    BMB REPORTS, 2014, 47 (06) : 311 - 317
  • [30] Therapeutic strategy in the treatment of pulmonary arterial hypertension
    Perrone, Sergio V.
    INSUFICIENCIA CARDIACA, 2009, 4 (01) : 33 - 43
12345